Top Suppliers:I want be here


  • DC Chemicals Limited
  • China
  • Product Name: TPI-1
  • Price: $500.0/100mg $850.0/250mg $1500.0/1g
  • Purity: 98.0%
  • Stocking Period: 3 Day
  • Contact: Tony Cao

79756-69-7

79756-69-7 structure
79756-69-7 structure
  • Name: TPI-1
  • Chemical Name: 2-(2,5-dichlorophenyl)cyclohexa-2,5-diene-1,4-dione
  • CAS Number: 79756-69-7
  • Molecular Formula: C12H6Cl2O2
  • Molecular Weight: 253.08100
  • Catalog: Signaling Pathways Metabolic Enzyme/Protease Phosphatase
  • Create Date: 2017-02-25 04:35:32
  • Modify Date: 2024-01-09 13:23:37
  • TPI-1 is a SHP-1 inhibitor; inhibits recombinant SHP-1 with an IC50 of 40 nM.

Name 2-(2,5-dichlorophenyl)cyclohexa-2,5-diene-1,4-dione
Synonyms TPI-1
Description TPI-1 is a SHP-1 inhibitor; inhibits recombinant SHP-1 with an IC50 of 40 nM.
Related Catalog
Target

IC50: 40 nM (recombinant SHP-1)[1]

In Vitro SHP-1 has been implicated as a potential cancer therapeutic target. TPI-1 is effective starting at 10 ng/mL in increasing SHP-1 phospho-substrates pLck-pY394. TPI-1 selectively increases SHP-1 phospho-substrates (pLck-pY394, pZap70 and pSlp76) in Jurkat T cells but has little effects on pERK1/2 or pLck-pY505. TPI-1 induces mouse splenic-IFNγ+ cells and induces IFNγ+ cells in human peripheral blood[1].
In Vivo TPI-1 inhibits the growth of B16 melanoma tumors in mice at a tolerated oral dose in a T cell-dependent manner but has little effects on B16 cell growth in culture. TPI-1 thus also increases pLck-pY394 and IFNγ+ cells in mice. TPI-1 also inhibits B16 tumor growth and prolongs tumor mice survival as a tolerated s.c. agent[1].
Animal Admin Mice: For in vivo induction of pLck-pY394 and IFNγ+ cells in mice, C57BL/6J mice are treated with PBS or TPI-1 (1 or 3 mg/kg, s.c.) for 4 days. Spleens are harvested one hour post-treatment on day 4 and processed into splenocytes, which are used for assessing pLck-pY394 levels by SDS-PAGE/Western blotting and for quantification of IFNγ+ cells by ELISPOT assays. Mice are also treated with TPI-1 (10 mg/kg, daily, s.c.) to evaluate the toxicity of the compounds in vivo[1].
References

[1]. Kundu S, et al. Novel SHP-1 inhibitors tyrosine phosphatase inhibitor-1 and analogs with preclinical anti-tumor activities as tolerated oral agents. J Immunol. 2010 Jun 1;184(11):6529-36.

Molecular Formula C12H6Cl2O2
Molecular Weight 253.08100
Exact Mass 251.97400
PSA 34.14000
LogP 3.08480
Storage condition 2-8℃
Precursor  3

DownStream  0